Clinical trialPhase 1Recruiting
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies: A Prospective, Phase I Clinical Trial
- Outcome
- Ongoing
- Phase
- Phase 1
- Status
- Recruiting
- Study type
- Interventional
- Start
- 1 August 2026
- Expected end
- 31 May 2028
- Enrollment
- 9 participants
- Sites
- 1
- Primary outcomes
- Incidence of Treatment-Related Adverse Events
- Sponsor
- Other
- Results posted
- No
- Last update
- 13 August 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try